Want to know more about CJC-1295? If so, the research article below may intrest you ...
CJC 1295 with DAC is a 30 amino acid peptide with a molecular formula of is C152H252N44O42 and a molecular weight of 3368.7. It is tetrasubstituted in nature, meaning that it is a functional group of atoms in which a quartet of hydrogen atoms has been replaced by another atom or group.
According to scientific study on animal test subjects, the prime mover that enables CJC 1295 with DAC to function in the matter that it does is linked to the peptide GHRH1-29. The peptide’s discharge is related to the negative feedback loop that is connected with a hormone axis that is found within animal test subjects. This axis is essentially responsible for the regulation of a certian hormone in order to provide a consistent level of homeostasis. GHRH1-29’s capabilities somewhat falter due to its rapid half-life; a process that completes in less than seven minutes.
CJC 1295 with DAC has been shown to aid in boosting this level of regulation because it is able to improve GHRH1-29’s half-life dramatically. With the presence of the peptide, the half-life can be boosted to a rate of greater than seven days, thus creating a peptide that is significantly more stabilized. This not only allows for a greater sense of regulatory process, it also leads to a more efficient means for an animal test subject to maintain a level of homeostasis.
Additionally, CJC 1295 with DAC has been shown to improve bioactivity, block methionine oxidation, and decrease asparagines rearrangement or amide hydrolysis to asparatic acid. CJC 1295 with DAC’s functionality has also been shown to have a significantly more positive effect on the act of lipolysis; that is, the manner in which adipose tissue or body fat can be broken down.
According to scientific study on animal test subjects, it has been determined that CJC 1295 with DAC has been linked to a host of different theorized benefits.
The first and arguably most obvious theorized benefit is that of an increased protein synthesis. Because CJC 1295 with DAC’s effect on GHRH1-29’s half-life and therefore its regulatory processes, it has been speculated that the peptide can elevate the process in which proteins are produced on a cellular level. This theory is further boosted by the notion that CJC 1295 with DAC can stop the process of natural cellular degradation from occurring.
The second theoretical benefit that has been linked involves the reduction of body fat. CJC 1295 with DAC’s presence has been shown to boost the rate at which fat gets broken down. When this process is coupled with the notion that the peptide can increase the speed of protein synthesis, the theorized result is an animal test subject’s body that can break down adipose tissue at a significantly more efficient rate.
Another benefit that has been put forth is tied to the growth of muscle tissue. Much like the link between the increased protein synthesis and the breakdown of body fat, CJC 1295 with DAC’s elevated process in which protein gets converted into energy means that a larger proliferation of cells can be created. This in turn enables an amplification of the mass and size of muscles that are found within animal test subjects.
There has also been a link to CJC 1295 with DAC and increased bone density. Scientific study that has been conducted on animal test subjects has determined that the peptide’s presence over a period of time can cause the generation of a bone’s mineral matter per square centimeter to boost over a given time frame. This in turn allows the bones to become stronger and less susceptible to injury.
CJC-1295 No DAC is a 30-amino acid peptide hormone that is tetrasubstituted in nature. It has a chemical formula of C152H252N44O42, and its molecular weight is 3367.2. Its functionality is marked by its ability to bioconjugate with the globular protein serum albumin, meaning that it has the capacity to pair up two biomolecules together to form a chemical bond.
In essence, CJC-1295 No DAC functions in conjunction with the peptide chain GHRH1-29. The discharge of this specific peptide relates to the negative feedback loop in animal test subjects. The negative feedback loop is basically what controls and regulates a hormone axis, a series of secretions that is responsible for several endocrine system-related processes, including:
Because GHRH1-29 relates to the growth hormone axis, it naturally plays a vital role in allowing an animal test subject to achieve and maintain a level of homeostasis. However, the caveat to this is that the peptide has a rapid half-life that lasts less than seven minutes.
However, scientific study on animal test subjects has concluded that CJC-1295 No DAC dramatically increases GHRH1-29’s half-life by a significant amount, to a time interval of over seven days. This enables the peptide to position itself to improve its functionality and biological activity within animal test subjects. In addition, CJC-1295 No DAC shows an ability to increase GHRH1-29s absorptive properties. CJC-1295 No DAC is also responsible for the following processes:
In essence, these processes cause the growth hormone axis in animal test subjects to stay active for a much longer interval of time.
According to scientific study conducted on animal test subjects, it is believed that CJC-1295 No DAC could possess a host of theoretical benefits.
One of the more prominent benefits linked to the peptide is the boosting of protein synthesis. Studies have led to the theory that the peptide’s ability to prevent natural cellular degradation can increase the amount of proteins in animal test subjects. Another theorized benefit revolves around the notion of reduced body fat, as the peptide’s mechanics have demonstrated a tendency to promote lipolysis, which is the process where lipids get broken down. As a result of this accelerated degradation of lipids over time, the level of body fat within an animal test subject has shown signs of dropping. Additionally, it is thought that the peptide’s ability to boost proteins can lead to an amplification of the mass and size of muscles found within animal test subjects. Other theoretical benefits that have been linked to CJC-1295 No-DAC through scientific study of animal test subjects include increased bone density, a stronger immune system, elevated memory retention, and expedited recovery from injury.
According to scientific study on animal test subjects, CJC-1295 No DAC has been determined to show a tendency to induce a greater, more consistent level of deep sleep, also known as slow wave sleep. The studies hypothesize that the peptide’s ability to promote muscle growth and memory retention also acts to extend the amount of deep sleep that is induced, since the peak level of both processes have a tendency to occur during this segment of the sleeping pattern. That said, the studies also demonstrate that the benefit shows a tendency to dissipate over time.
Although there have been a lot of research and study tied to CJC-1295 No DAC and its overall functionality, operational mechanics, theorized benefits, and negative side effects, it should be remembered that all of the research and subsequent findings has been a product of scientific study based on animal test subjects. The peptide is solely intended for the use of scientific study at the current time. Therefore, any findings or observations relating to CJC-1295 No DAC’s overall functionality, mechanics, or theoretical benefits should only be contained to the strict confines of a controlled environment such as a medical research facility or a laboratory.
We have more releated research in our research center. Click here to read more.